{
  "created_at": "2021-11-05T14:21:58.709Z",
  "title": "Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%",
  "url": "https://www.fiercebiotech.com/biotech/pfizer-s-oral-covid-19-antiviral-cuts-hospitalization-death-by-85-sending-team-barreling-to",
  "author": "jeremylevy",
  "points": 871,
  "num_comments": 183,
  "_tags": [
    "story",
    "author_jeremylevy",
    "story_29118534",
    "front_page"
  ],
  "objectID": "29118534",
  "original_created_at": "2021-11-05T12:57:14.000Z",
  "image": "https://qtxasset.com/fiercebiotech/1636112595/GettyImages-1293456793.jpg/GettyImages-1293456793.jpg?VersionId=PXQxlKjoCLRXFFh8P8hLmDf8J1X0cucx",
  "localize": [
    {
      "locale": "ja",
      "title": "ファイザー社の経口抗ウイルス剤「Covid-19」が入院・死亡を85％削減"
    },
    {
      "locale": "zh",
      "title": "辉瑞公司的口服Covid-19抗病毒药物将住院和死亡人数减少了85%。"
    },
    {
      "locale": "zh-Hant",
      "title": "輝瑞公司的口服Covid-19抗病毒藥物將住院和死亡人數減少了85%。"
    }
  ],
  "source_updated_at": 1636710071924
}